Blueberries Medical (CNSX:BBM) - Stock Price, News & Analysis

BBM Stock Overview

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. More details

BBM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Does not have a meaningful market cap (CA$6M)

Has less than 1 year of cash runway

Makes less than USD$1m in revenue (CA$288K)

Blueberries Medical Corp. Competitors

Delivra Health Brands

TSXV:DHB

CA$6.3m

CanadaBis Capital

TSXV:CANB

CA$6.9m

Avant Brands

TSX:AVNT

CA$6.9m

Ayurcann Holdings

CNSX:AYUR

CA$6.8m

Price History & Performance

Summary of all time highs, changes and price drops for Blueberries Medical
Historical stock prices
Current Share Price	CA$0.015
52 Week High	CA$0.04
52 Week Low	CA$0.005
Beta	1.99
11 Month Change	-25.00%
3 Month Change	0%
1 Year Change	0%
33 Year Change	-78.57%
5 Year Change	-85.71%
Change since IPO	-97.00%

Recent updates

Shareholder Returns

	BBM	CA Pharmaceuticals	CA Market
7D	0%	-6.1%	0.7%
1Y	0%	-22.3%	21.7%

Return vs Industry: BBM exceeded the Canadian Pharmaceuticals industry which returned -22.8% over the past year.

Return vs Market: BBM underperformed the Canadian Market which returned 21.4% over the past year.

Price Volatility

Is BBM's price volatile compared to industry and market?
BBM volatility
BBM Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	11.5%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.6%
10% least volatile stocks in CA Market	2.9%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine BBM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Facundo Garreton	blueberriesmed.com

Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. The company is based in Vancouver, Canada.

Blueberries Medical Corp. Fundamentals Summary

How do Blueberries Medical's earnings and revenue compare to its market cap?
BBM fundamental statistics
Market cap	CA$5.99m
Earnings (TTM)	-CA$1.29m
Revenue (TTM)	CA$288.29k

20.8x

P/S Ratio

-4.6x

P/E Ratio

Is BBM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BBM income statement (TTM)
Revenue	CA$288.29k
Cost of Revenue	CA$186.37k
Gross Profit	CA$101.92k
Other Expenses	CA$1.39m
Earnings	-CA$1.29m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0032
Gross Margin	35.35%
Net Profit Margin	-446.76%
Debt/Equity Ratio	0%

How did BBM perform over the long term?

See historical performance and comparison

BBM Stock Overview

Risk Analysis

Blueberries Medical Corp. Competitors

TSXV:DHB

CA$6.3m

TSXV:CANB

CA$6.9m

TSX:AVNT

CA$6.9m

CNSX:AYUR

CA$6.8m

Price History & Performance

Recent News & Updates

Second quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2023)

Blueberries Medical Corp., Annual General Meeting, Oct 18, 2024

First quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 1Q 2023)

New major risk - Financial position

Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 2Q 2022)

Recent updates

Second quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2023)

Blueberries Medical Corp., Annual General Meeting, Oct 18, 2024

First quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 1Q 2023)

New major risk - Financial position

Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 2Q 2022)

Blueberries Medical Corp., Annual General Meeting, Oct 06, 2023

First quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.004 loss in 1Q 2022)

Full year 2022 earnings released: CA$0.009 loss per share (vs CA$0.035 loss in FY 2021)

Third quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.003 loss in 3Q 2021)

Blueberries Medical Corp. announced that it has received CAD 1.47147 million in funding from Terraflos Inc.

Second quarter 2022 earnings released: CA$0.003 loss per share (vs CA$0.002 loss in 2Q 2021)

Blueberries Medical Corp., Annual General Meeting, Oct 07, 2022

High number of new directors

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

High number of new and inexperienced directors

High number of new and inexperienced directors

Less than half of directors are independent

Blueberries Medical Corp. announced that it has received CAD 1.901382 million in funding from Terraflos Inc.

Chief Financial Officer Ian Atacan has left the company

Blueberries Medical Corp. Appoints José María Forero as President of Latin American Operations, Effective February 16, 2021

New 90-day high: CA$0.23

Blueberries Medical Corp. Announces Management Changes

Blueberries Medical Corp. Receives Approval from the Colombian Agricultural Institute for the Registration of Nine Psychoactive Tetrahydrocannabinol Dominant Strains

Blueberries Medical Corp. announced that it has received CAD 1 million in funding

Shareholder Returns

Price Volatility

About the Company

Blueberries Medical Corp. Fundamentals Summary

20.8x

-4.6x

Earnings & Revenue